Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

Pfizer will receive around £2.7 billion in aggregate from Haleon from an offering and a share buyback.

Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcic as General Manager, Haleon ...

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

Skyrizi had an estimated national TV ad spend of $93.7 million — the highest amount of any brand in the top 10 during this ...

Pfizer has offloaded a £2.43billion stake in consumer health spin-out Haleon, which said it would buy back £230million of the ...

Pfizer has divested a $3.3 billion stake in Haleon, reducing its holding in the British consumer healthcare company.

Pfizer (PFE) reduces its stake in Haleon to 15% from 22.6% by selling £2.45B worth of shares, continuing its gradual ...

Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6% ...

Separately, Haleon will also buy around £230 million worth of its shares from Pfizer at the price set in the share offering, ...